ArticleFood science & nutrition2026
Sinapine Modulates Glycogen and Lipid Synthesis via IRS1-PI3K-AKT-GSK3β-GS Pathway in Insulin-Resistant Models.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sinapine Modulates Glycogen and Lipid Synthesis via IRS1-PI3K-AKT-GSK3β-GS Pathway in Insulin-Resistant Models.Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the effects of sinapine on glycogen synthesis and lipid metabolism in insulin-resistant HepG2 cell models and type 2 diabetes mellitus (T2DM) mice. Network pharmacology analysis integrated 288 potential sinapine targets and 920 insulin resistance-related targets, yielding 72 overlapping genes. KEGG enrichment of these genes identified one significantly enriched insulin resistance pathway, with target mapping concentrated on the IRS1-PI3K-AKT-GSK3β-GS axis, suggesting a key role in promoting hepatic glycogen synthesis. Molecular docking identified these key targets on this signaling pathway, with sinapine showing strong binding affinity to its nuclear proteins (below -4.0 kcal/mol). In vitro, sinapine treatment improved glucose uptake and glycogen synthesis, while reducing lipogenesis, lipid accumulation, and reactive oxygen species (ROS) levels. RT-qPCR and Western blot analyses confirmed that sinapine increases glycogen synthase activity. In T2DM mice, sinapine improved glucose and lipid metabolism, enhanced insulin sensitivity, and reduced blood glucose levels. Additionally, sinapine attenuated weight loss, improved liver index and histology, and regulated serum lipid profiles. Overall, this study reveals the molecular mechanism of sinapine in mitigating insulin resistance via modulation of the IRS1-PI3K-AKT-GSK3β-GS pathway, offering theoretical support for its potential application as a nutritional intervention to improve carbohydrate and lipid metabolism.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.